Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication 
Lisinopril
Potential treatment - theoretical effect Used to treat other disease Antiviral Apr/30/2020
Merimepodib
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
Midostaurin
Potential treatment - theoretical effect Used to treat other disease Antiviral Apr/30/2020
Migalastat
Potential treatment - theoretical effect Used to treat other disease Antiviral Apr/30/2020
Indomethacin
Potential treatment - theoretical effect Used to treat other disease Antiviral Apr/30/2020
FK-506
Potential treatment - theoretical effect Used to treat other disease Antiviral Apr/30/2020
GB110
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
H-89
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
IHVR-19029
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
CPI-0610
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
Dabrafenib
Potential treatment - theoretical effect Used to treat other disease Antiviral Apr/30/2020
DBET6
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
E-52862
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
AZ3451
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
AZ8838
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
Captopril
Potential treatment - theoretical effect Used to treat other disease Antiviral Apr/30/2020
CCT 365623
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
Chloramphenicol
Potential treatment - theoretical effect Used to treat other disease Antiviral Apr/30/2020
Compound 10
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
Compound 2
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020